University of Pittsburgh Cancer Institute-Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Pittsburgh Cancer Institute-Hillman Cancer Center has participated in 16 clinical trials with 1 currently active.
Therapeutic areas: Breast Cancer, Advanced Incurable Solid Malignancy, Non Small Cell Lung Cancer (NSCLC).
Sponsors: Alliance Foundation Trials, LLC., Leonard Appleman, Theresa Whiteside, PhD.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Cancer Institute-Hillman Cancer Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Cancer Institute-Hillman Cancer Center has 16 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Advanced Incurable Solid Malignancy, Non Small Cell Lung Cancer (NSCLC).
University of Pittsburgh Cancer Institute-Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.